Physician profile
Juan C Rolon
NPI 1225036692
$1,626.82
in general payments reported to CMS, 2019-2025
19 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $465 · 2022: $116 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $386.78 | 2019-2020 | |
| Avion Pharmaceuticals | $309.70 | 2019-2020 | |
| Intuitive Surgical, INC. | $133.75 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.12 | 2019-2020 | |
| Medtronic, INC. | $116.05 | 2022 | |
| Organon LLC | $105.43 | 2025 | |
| Lupin INC. | $86.29 | 2019-2020 | |
| Pfizer INC. | $73.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $52.26 | 2019-2020 | |
| Allergan, INC. | $47.84 | 2019 | |
| Coopersurgical, INC. | $31.63 | 2019 | |
| Duchesnay USA Incorporated | $30.25 | 2019 | |
| Vertical Pharmaceuticals, LLC | $26.87 | 2019 | |
| Exeltis, USA INC. | $26.54 | 2019 | |
| Therapeuticsmd, INC. | $26.43 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $17.27 | 2019 | |
| Radius Health, INC. | $15.44 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.98 | 2019 | |
| Hologic Sales and Service, LLC | $11.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Rolon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.